100 related articles for article (PubMed ID: 2458448)
1. Pharmacological characterization of muscarinic receptors mediating inhibition of adenylate cyclase activity in the rat retina.
Qu ZX; Fertel R; Neff NH; Hadjiconstantinou M
J Pharmacol Exp Ther; 1988 Sep; 246(3):839-42. PubMed ID: 2458448
[TBL] [Abstract][Full Text] [Related]
2. M-1 and M-2 muscarinic receptor-mediated inhibition of dopamine-sensitive adenylate cyclase in rat neostriatum: a permissive role for D-2 dopamine receptors.
Schoffelmeer AN; Hogenboom F; Mulder AH
J Pharmacol Exp Ther; 1988 May; 245(2):658-63. PubMed ID: 2452877
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological basis for functional selectivity of partial muscarinic receptor agonists.
Heldman E; Barg J; Fisher A; Levy R; Pittel Z; Zimlichman R; Kushnir M; Vogel Z
Eur J Pharmacol; 1996 Feb; 297(3):283-91. PubMed ID: 8666061
[TBL] [Abstract][Full Text] [Related]
4. Pirenzepine distinguishes between muscarinic receptor-mediated phosphoinositide breakdown and inhibition of adenylate cyclase.
Gil DW; Wolfe BB
J Pharmacol Exp Ther; 1985 Mar; 232(3):608-16. PubMed ID: 2579230
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of muscarinic receptors potentiating the stimulation of adenylyl cyclase activity by corticotropin-releasing hormone in membranes of rat frontal cortex.
Onali P; Olianas MC
J Pharmacol Exp Ther; 1998 Aug; 286(2):753-9. PubMed ID: 9694930
[TBL] [Abstract][Full Text] [Related]
6. Pathways involved in muscarinic M1 and M2 receptor stimulation in rabbit vas deferens.
Eltze M
Eur J Pharmacol; 1994 Sep; 263(1-2):31-7. PubMed ID: 7529712
[TBL] [Abstract][Full Text] [Related]
7. Activation of muscarinic acetylcholine receptors elicits pigment granule dispersion in retinal pigment epithelium isolated from bluegill.
González A; Crittenden EL; García DM
BMC Neurosci; 2004 Jul; 5():23. PubMed ID: 15251036
[TBL] [Abstract][Full Text] [Related]
8. Muscarinic receptor-mediated phosphoinositide hydrolysis in the rat retina.
Moroi-Fetters SE; Neff NH; Hadjiconstantinou M
J Pharmacol Exp Ther; 1988 Aug; 246(2):553-7. PubMed ID: 2841451
[TBL] [Abstract][Full Text] [Related]
9. Modulation of muscarinic receptor-mediated adenylate cyclase and phospholipase C responses in rat retina.
Hadjiconstantinou M; Moroi-Fetters SE; Qu SZ; Neff NH
Cell Mol Neurobiol; 1991 Oct; 11(5):455-62. PubMed ID: 1660349
[TBL] [Abstract][Full Text] [Related]
10. Dissociation between muscarinic receptor-mediated inhibition of adenylate cyclase and autoreceptor inhibition of [3H] acetylcholine release in rat hippocampus.
Vickroy TW; Cadman ED
J Pharmacol Exp Ther; 1989 Dec; 251(3):1039-44. PubMed ID: 2557410
[TBL] [Abstract][Full Text] [Related]
11. Involvement of M1-muscarinic receptors in the excitation of neocortical neurones by acetylcholine.
Bradshaw CM; Sheridan RD; Szabadi E
Neuropharmacology; 1987 Aug; 26(8):1195-200. PubMed ID: 2443871
[TBL] [Abstract][Full Text] [Related]
12. AF64A lesions of mouse striatum result in ipsilateral rotations to D2 dopamine agonists but contralateral rotations to muscarinic cholinergic agonists.
Zhou LW; Zhang SP; Connell TA; Weiss B
J Pharmacol Exp Ther; 1993 Feb; 264(2):824-30. PubMed ID: 8094754
[TBL] [Abstract][Full Text] [Related]
13. Acetylcholine-induced biphasic effect on the maximum upstroke velocity of action potential in mouse right atria: interaction with beta-adrenergic signaling cascade.
Islam MA; Nojima H; Kimura I
Jpn J Pharmacol; 1998 Oct; 78(2):181-90. PubMed ID: 9829621
[TBL] [Abstract][Full Text] [Related]
14. Interactions of agonists with M2 and M4 muscarinic receptor subtypes mediating cyclic AMP inhibition.
McKinney M; Miller JH; Gibson VA; Nickelson L; Aksoy S
Mol Pharmacol; 1991 Dec; 40(6):1014-22. PubMed ID: 1722002
[TBL] [Abstract][Full Text] [Related]
15. Ethylcholine aziridinium ion depletes acetylcholine and causes muscarinic receptor supersensitivity in rat retina.
Moroi-Fetters SE; Neff NH; Hadjiconstantinou M
Neurosci Lett; 1990 Feb; 109(3):304-8. PubMed ID: 2330132
[TBL] [Abstract][Full Text] [Related]
16. Specific inhibition of isoproterenol-stimulated cyclic AMP accumulation by M2 muscarinic receptors in rat intestinal smooth muscle.
Griffin MT; Ehlert FJ
J Pharmacol Exp Ther; 1992 Oct; 263(1):221-5. PubMed ID: 1328607
[TBL] [Abstract][Full Text] [Related]
17. Estimation of agonist activity at G protein-coupled receptors: analysis of M2 muscarinic receptor signaling through Gi/o,Gs, and G15.
Griffin MT; Figueroa KW; Liller S; Ehlert FJ
J Pharmacol Exp Ther; 2007 Jun; 321(3):1193-207. PubMed ID: 17392404
[TBL] [Abstract][Full Text] [Related]
18. Muscarinic-dopaminergic synergism on retinal cyclic AMP formation.
Brown JH; Rietow M
Brain Res; 1981 Jun; 215(1-2):388-92. PubMed ID: 6266579
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological evidence for distinct muscarinic receptor subtypes coupled to the inhibition of adenylate cyclase and to the increased generation of inositol phosphates in the guinea pig myometrium.
Leiber D; Marc S; Harbon S
J Pharmacol Exp Ther; 1990 Feb; 252(2):800-9. PubMed ID: 2156062
[TBL] [Abstract][Full Text] [Related]
20. Modulation of hippocampal norepinephrine release by cholinergic agonists is altered by AF64A lesion.
Potter PE; Thorne B; Gaughan C
Brain Res Bull; 1997; 42(2):153-60. PubMed ID: 8971421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
